RESUMO
No disponible
Assuntos
Humanos , Neoplasias/complicações , Distúrbios Nutricionais/epidemiologia , Desnutrição/dietoterapia , Terapia Nutricional/métodos , Avaliação de Resultado de Intervenções Terapêuticas , Apoio Nutricional/métodos , Fatores de Risco , Anorexia/dietoterapia , Náusea/dietoterapia , Constipação Intestinal/dietoterapia , Transtornos de Deglutição/dietoterapiaRESUMO
No disponible
Assuntos
Humanos , Neoplasias/complicações , Distúrbios Nutricionais/epidemiologia , Estilo de Vida Saudável , Terapia Nutricional/métodos , Nutrientes , Micronutrientes/uso terapêutico , Terapia por Exercício , Padrões de Prática MédicaRESUMO
INTRODUCTION: The purpose of this phase II study was to evaluate the efficacy and safety of neoadjuvant docetaxel/gemcitabine treatment in a biweekly regimen. MATERIALS AND METHODS: Patients with stage II/III breast cancer were treated with docetaxel (65 mg/m(2)) followed by gemcitabine (2500 mg/m(2)) every 2 weeks for 6 cycles. Patients with a clinical response or stable disease underwent mastectomy or breast-conserving surgery plus axillary dissection. After surgery, patients received 4 cycles of standard doxorubicin 60 mg/m(2) and cyclophosphamide 600 mg/m(2) every 21 days. RESULTS: Thirty-five patients were included in the trial. The overall response rate was 71.4% (95% CI: 53.7-85.4), with 8 complete and 17 partial responses. Breast conservation was possible in 59% of the patients. Toxicity was manageable. CONCLUSIONS: We consider biweekly docetaxel and gemcitabine could be an active and tolerable regimen option in the neoadjuvant setting sequentially with standard adjuvant doxorubicin-cyclophosphamide in patients with stage II or III breast cancer (AU)
Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Ensaios Clínicos Fase II como Assunto/métodos , Ensaios Clínicos Fase II como Assunto , Antineoplásicos/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Ciclofosfamida/uso terapêutico , Doxorrubicina/uso terapêutico , Desoxicitidina/uso terapêutico , Cronoterapia/métodos , Taxoides/administração & dosagem , Quimioterapia Adjuvante/métodos , Esquema de Medicação , Terapia Neoadjuvante , Estadiamento de Neoplasias/métodos , Estadiamento de NeoplasiasRESUMO
1. Ageing represents a great concern in developed countries because the number of people involved and the pathologies related with it, like atherosclerosis, morbus Parkinson, Alzheimer's disease, vascular dementia, cognitive decline, diabetes and cancer. 2. Epidemiological studies suggest that a Mediterranean diet (which is rich in virgin olive oil) decreases the risk of cardiovascular disease. 3. The Mediterranean diet, rich in virgin olive oil, improves the major risk factors for cardiovascular disease, such as the lipoprotein profile, blood pressure, glucose metabolism and antithrombotic profile. Endothelial function, inflammation and oxidative stress are also positively modulated. Some of these effects are attributed to minor components of virgin olive oil. Therefore, the definition of the Mediterranean diet should include virgin olive oil. 4. Different observational studies conducted in humans have shown that the intake of monounsaturated fat may be protective against age-related cognitive decline and Alzheimer's disease. 5. Microconstituents from virgin olive oil are bioavailable in humans and have shown antioxidant properties and capacity to improve endothelial function. Furthermore they are also able to modify the haemostasis, showing antithrombotic properties. 6. In countries where the populations fulfilled a typical Mediterranean diet, such as Spain, Greece and Italy, where virgin olive oil is the principal source of fat, cancer incidence rates are lower than in northern European countries. 7. The protective effect of virgin olive oil can be most important in the first decades of life, which suggests that the dietetic benefit of virgin olive oil intake should be initiated before puberty, and maintained through life. 8. The more recent studies consistently support that the Mediterranean diet, based in virgin olive oil, is compatible with a healthier ageing and increased longevity. However, despite the significant advances of the recent years, the final proof about the specific mechanisms and contributing role of the different components of virgin olive oil to its beneficial effects requires further investigations.